244 related articles for article (PubMed ID: 22479330)
1. Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
Hannoun S; Bagory M; Durand-Dubief F; Ibarrola D; Comte JC; Confavreux C; Cotton F; Sappey-Marinier D
PLoS One; 2012; 7(3):e32525. PubMed ID: 22479330
[TBL] [Abstract][Full Text] [Related]
2. Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.
Tiberio M; Chard DT; Altmann DR; Davies G; Griffin CM; McLean MA; Rashid W; Sastre-Garriga J; Thompson AJ; Miller DH
J Neurol; 2006 Feb; 253(2):224-30. PubMed ID: 16307201
[TBL] [Abstract][Full Text] [Related]
3. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
[TBL] [Abstract][Full Text] [Related]
4. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
[TBL] [Abstract][Full Text] [Related]
5. Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS.
Kirov II; Tal A; Babb JS; Herbert J; Gonen O
Neurology; 2013 Jan; 80(1):39-46. PubMed ID: 23175732
[TBL] [Abstract][Full Text] [Related]
6. Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging.
Sun J; Song H; Yang Y; Zhang K; Gao X; Li X; Ni L; Lin P; Niu C
Medicine (Baltimore); 2017 Apr; 96(14):e6534. PubMed ID: 28383419
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
8. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.
Inglese M; Li BS; Rusinek H; Babb JS; Grossman RI; Gonen O
Magn Reson Med; 2003 Jul; 50(1):190-5. PubMed ID: 12815694
[TBL] [Abstract][Full Text] [Related]
9. Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.
Aboul-Enein F; Krssák M; Höftberger R; Prayer D; Kristoferitsch W
PLoS One; 2010 Jul; 5(7):e11625. PubMed ID: 20652023
[TBL] [Abstract][Full Text] [Related]
10. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL
Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491
[TBL] [Abstract][Full Text] [Related]
11. Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis.
Klauser AM; Wiebenga OT; Eijlers AJ; Schoonheim MM; Uitdehaag BM; Barkhof F; Pouwels PJ; Geurts JJ
Mult Scler; 2018 Apr; 24(4):491-500. PubMed ID: 28406063
[TBL] [Abstract][Full Text] [Related]
12. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
[TBL] [Abstract][Full Text] [Related]
13. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
[TBL] [Abstract][Full Text] [Related]
14. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
15. Correlations between DTI-derived metrics and MRS metabolites in tumour regions of glioblastoma: a pilot study.
Flores-Alvarez E; Anselmo Rios Piedra E; Cruz-Priego GA; Durand-Muñoz C; Moreno-Jimenez S; Roldan-Valadez E
Radiol Oncol; 2020 Sep; 54(4):394-408. PubMed ID: 32990651
[TBL] [Abstract][Full Text] [Related]
16. Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis.
Tourbah A; Stievenart JL; Gout O; Fontaine B; Liblau R; Lubetzki C; Cabanis EA; Lyon-Caen O
Neurology; 1999 Sep; 53(5):1091-7. PubMed ID: 10496272
[TBL] [Abstract][Full Text] [Related]
17. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
[TBL] [Abstract][Full Text] [Related]
18. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
Sijens PE; Mostert JP; Oudkerk M; De Keyser J
Eur Radiol; 2006 Feb; 16(2):489-95. PubMed ID: 16028056
[TBL] [Abstract][Full Text] [Related]
19. Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis.
Kirov II; Liu S; Fleysher R; Fleysher L; Babb JS; Herbert J; Gonen O
Radiology; 2010 Mar; 254(3):858-66. PubMed ID: 20177098
[TBL] [Abstract][Full Text] [Related]
20. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
